Together, these results suggest that mitochondrial 1C metabolism sustains proliferation of CML cells both in vitro and in vivo, and cytosolic 1C metabolism does not fully compensate for the loss of SHMT2. Here, SHMT2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.